Certified by Founder Lodge
Bluejay Therapeutics
United States - San Francisco Bay Area
START UP
1 Disclosed Funding Rounds $182,000,000
0 Participating Investments
-
Founded date
2020
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
The mission of Bluejay Therapeutics is to develop innovative cures for infectious diseases with the first target indication of chronic HBV infection. Bluejay has exclusively licensed global r
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| May, 10 ,2024 | Series C | $182,000,000 |
Novo Holdings
Wellington Management
RA Capital Management, L.P.
T. Rowe Price
RiverVest Venture Partners
Frazier Life Sciences
Unicorn Capital
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Helex | $3,500,000 | (Nov 4, 2025)
xMEMS | $21,000,000 | (Nov 4, 2025)
catalyx space | $5,400,000 | (Nov 4, 2025)
Cephia AI | $4,000,000 | (Nov 4, 2025)
Ornn | $5,700,000 | (Nov 4, 2025)
